The agency in charge of Georgia’s medical cannabis program has awarded the first two production licenses for a product the General Assembly legalized seven years ago but that has yet to materialize.
The Georgia Commission for Access to Medical Cannabis voted this week to award licenses to Trulieve Georgia Inc. and Biological Sciences LLC to grow marijuana and convert the leafy crop into low-THC cannabis oil for sale to patients suffering from a range of diseases.
The commission issued tentative production licenses to six companies more than a year ago, including one that was set to produce cannabis products in the Trion Industrial Park in Chattooga County, but the process quickly bogged down when losing bidders filed protests claiming the selection of winners was unfair and arbitrary.
Georgia law allows low-THC cannabis oil to be used to treat patients with diseases including seizure disorders, Parkinson’s disease, terminal cancer, post-traumatic stress disorder and sickle-cell anemia.
Comments